Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
Clinical trial NCT05214183 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05214183
- Sponsor
- Nordic Lymphoma Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2027-01-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.